KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 23,784,064
- Share change
- -1,115,603
- Total reported value
- $314,614,009
- Put/Call ratio
- 84%
- Price per share
- $13.23
- Number of holders
- 93
- Value change
- -$24,155,895
- Number of buys
- 42
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.3%
|
2,163,554
|
$37,754,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.8%
|
1,930,322
|
$33,684,000 | — | 30 Sep 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
1,831,441
|
$31,958,000 | — | 30 Sep 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
3.2%
|
1,641,913
|
$28,651,000 | — | 30 Sep 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.1%
|
1,543,284
|
$26,930,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
1,416,642
|
$24,720,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.8%
|
1,400,459
|
$24,438,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,186,747
|
$20,709,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.3%
|
1,141,683
|
$19,923,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,043,828
|
$18,215,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
1.9%
|
960,960
|
$16,769,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
884,339
|
$15,432,000 | — | 30 Sep 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
665,681
|
$11,616,000 | — | 30 Sep 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.76%
|
383,233
|
$6,687,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
368,140
|
$6,424,000 | — | 30 Sep 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.62%
|
312,553
|
$5,454,000 | — | 30 Sep 2021 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.6%
|
304,113
|
$5,307,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.54%
|
274,853
|
$4,796,000 | — | 30 Sep 2021 | |
| Prosight Management, LP |
13F
|
Company |
0.51%
|
257,391
|
$4,491,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
233,740
|
$4,079,000 | — | 30 Sep 2021 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.43%
|
217,389
|
$3,794,000 | — | 30 Sep 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.4%
|
200,000
|
$3,490,000 | — | 30 Sep 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.37%
|
189,163
|
$3,301,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
170,208
|
$2,970,000 | — | 30 Sep 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
0.31%
|
156,807
|
$2,736,000 | — | 30 Sep 2021 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.27%
|
136,554
|
$2,383,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.24%
|
122,122
|
$2,351,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.26%
|
129,351
|
$2,257,000 | — | 30 Sep 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.25%
|
125,000
|
$2,181,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
122,643
|
$2,140,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.24%
|
120,422
|
$2,101,000 | — | 30 Sep 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.24%
|
120,000
|
$2,094,000 | — | 30 Sep 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.22%
|
111,834
|
$1,952,000 | — | 30 Sep 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.2%
|
100,000
|
$1,745,000 | — | 30 Sep 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.19%
|
96,576
|
$1,685,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.16%
|
80,170
|
$1,399,000 | — | 30 Sep 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.16%
|
78,720
|
$1,374,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
73,236
|
$1,278,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
69,295
|
$1,210,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
52,098
|
$910,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
40,872
|
$713,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
40,662
|
$710,000 | — | 30 Sep 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.08%
|
40,000
|
$698,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.08%
|
38,600
|
$674,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
36,715
|
$641,000 | — | 30 Sep 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
35,500
|
$619,000 | — | 30 Sep 2021 | |
| CSS LLC/IL |
13F
|
Company |
0.07%
|
34,999
|
$611,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
33,228
|
$580,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.06%
|
31,254
|
$545,000 | — | 30 Sep 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
30,779
|
$537,000 | — | 30 Sep 2021 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2021
As of 31 Dec 2021,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,784,064 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, SUVRETTA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, BlackRock Inc., Deep Track Capital, LP, FRAZIER MANAGEMENT LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VANGUARD GROUP INC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
101
Q4 2021 holders
93
Holder diff
-8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.